FDA Device recall Z-1704-2016
Novocastra Liquid Mouse Monoclonal Antibody Calretinin, NCL-L-CALRET-566
- FDA Device
- Class II
- terminated
- Published 2016-06-01
On 2016-06-01 the FDA classified a Class II recall of Novocastra Liquid Mouse Monoclonal Antibody Calretinin, NCL-L-CALRET-566 by Leica Microsystems, citing novocastra Liquid Mouse Monoclonal Antibody Calretinin when used in combination with specific Lots of antibody diluent will give reduced staining.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1704-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-03-22 |
| Published | 2016-06-01 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | Leica Microsystems |
| Distribution | AK, CA, FL, GA, MN, MT, NJ, OH, TX, WA |
Product
Novocastra Liquid Mouse Monoclonal Antibody Calretinin, NCL-L-CALRET-566. Intended for the qualitative identification by light microscopy of human calretinin molecule in paraffin sections.
Reason
Novocastra Liquid Mouse Monoclonal Antibody Calretinin when used in combination with specific Lots of antibody diluent will give reduced staining.
Identifiers
| code_info | Lot numbers: 6025204, 6029060, 6029949, 6035923 and 6036060. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1704-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.